102 related articles for article (PubMed ID: 7038839)
1. Gastrointestinal protection by low-dose oral prostaglandin E2 in rheumatic diseases.
Kollberg B; Nordemar R; Johansson C
Scand J Gastroenterol; 1981; 16(8):1005-8. PubMed ID: 7038839
[TBL] [Abstract][Full Text] [Related]
2. Protective effect of prostaglandin E2 in the gastrointestinal tract during indomethacin treatment of rheumatic diseases.
Johansson C; Kollberg B; Nordemar R; Samuelson K; Bergström S
Gastroenterology; 1980 Mar; 78(3):479-83. PubMed ID: 7351286
[TBL] [Abstract][Full Text] [Related]
3. Prevention of aspirin-induced fecal blood loss with oral prostaglandin E2: dose-response studies in man.
Cohen MM
Prostaglandins; 1981; 21 Suppl():155-60. PubMed ID: 7029648
[TBL] [Abstract][Full Text] [Related]
4. Prostaglandin E2 tablets prevent aspirin-induced blood loss in man.
Yik KY; Dreidger AA; Watson WC
Dig Dis Sci; 1982 Nov; 27(11):972-5. PubMed ID: 6982803
[TBL] [Abstract][Full Text] [Related]
5. Effect of oral and intravenous 16,16-dimethyl prostaglandin E2 in duodenal ulcer and Zollinger-Ellison syndrome patients.
Ippoliti AF; Isenberg JI; Hagie L
Gastroenterology; 1981 Jan; 80(1):55-9. PubMed ID: 7450412
[TBL] [Abstract][Full Text] [Related]
6. Mucosal protection by prostaglandin E2.
Johansson C; Kollberg B; Nordemar R; Bergström S
Lancet; 1979 Feb; 1(8111):317. PubMed ID: 84963
[No Abstract] [Full Text] [Related]
7. Prevention of aspirin-induced fecal blood loss in men with prostaglandin E2.
Cohen MM; Cheung G; Lyster DM
Adv Prostaglandin Thromboxane Res; 1980; 8():1525-8. PubMed ID: 6990723
[No Abstract] [Full Text] [Related]
8. Prevention of aspirin-induced faecal blood loss by prostaglandin E2.
Cohen MM; Cheung G; Lyster DM
Gut; 1980 Jul; 21(7):602-6. PubMed ID: 7000631
[TBL] [Abstract][Full Text] [Related]
9. The inhibitory effect of 15(R)15 methyl prostaglandin E2 and the interaction with atropine on stimulated gastric acid secretion in man.
Kollberg B; Johansson C
Scand J Gastroenterol; 1979; 14(3):337-42. PubMed ID: 375376
[TBL] [Abstract][Full Text] [Related]
10. Clinical trials with prostaglandin E2.
Johansson C; Kollberg B
Prostaglandins; 1981; 21 Suppl():161-4. PubMed ID: 7029649
[No Abstract] [Full Text] [Related]
11. Effects of prostaglandin E1, E2 and 16,16-dimethyl-E2 on gastric mucosal microcirculation and basal acid output in the rat.
Holm-Rutili L
Acta Physiol Scand; 1986 Jul; 127(3):313-21. PubMed ID: 3463127
[TBL] [Abstract][Full Text] [Related]
12. Effect of 15(R),15-methyl prostaglandin E2 and indomethacin on pancreatic secretion in man.
Saad C; Dooley CP; Valenzuela JE
Dig Dis Sci; 1987 May; 32(5):487-93. PubMed ID: 2436865
[TBL] [Abstract][Full Text] [Related]
13. Prostaglandin E2 administration in infants with ductus-dependent cyanotic congenital heart disease.
Thanopoulos BD; Andreou A; Frimas C
Eur J Pediatr; 1987 May; 146(3):279-82. PubMed ID: 3474149
[TBL] [Abstract][Full Text] [Related]
14. Treatment of mouse carcinoma in vivo with a prostaglandin E2 analogue and indomethacin.
Bennett A; Carroll MA; Melhuish PB; Stamford IF
Br J Cancer; 1985 Aug; 52(2):245-9. PubMed ID: 4027166
[TBL] [Abstract][Full Text] [Related]
15. Protective effect of low dose of enprostil against gastric blood loss induced by aspirin in man.
Thiefin G; Fierfort E; Duchateau A; Garbe E; Joubert M; Zeitoun P
Scand J Gastroenterol; 1989 Sep; 24(7):827-32. PubMed ID: 2508213
[TBL] [Abstract][Full Text] [Related]
16. Effect of methylated prostaglandin E2 analogue on insulin secretion in man.
Konturek SJ; Mikoś EM; Król R; Wierzbicki Z; Dobrzańska M
Prostaglandins; 1978 Apr; 15(4):591-602. PubMed ID: 674691
[TBL] [Abstract][Full Text] [Related]
17. Gastric antisecretory and antiulcer properties of PGE2, 15-methyl PGE2, and 16, 16-dimethyl PGE2. Intravenous, oral and intrajejunal administration.
Robert A; Schultz JR; Nezamis JE; Lancaster C
Gastroenterology; 1976 Mar; 70(3):359-70. PubMed ID: 174967
[TBL] [Abstract][Full Text] [Related]
18. Effects of prostaglandins and their methylated analogues upon human adenylate cyclase in the upper gastrointestinal tract.
Simon B; Kather H; Kommerell B
Digestion; 1978; 17(6):547-53. PubMed ID: 710739
[TBL] [Abstract][Full Text] [Related]
19. The use of 16,16-dimethyl-trans delta 2 prostaglandin E1 methyl ester (gemeprost) vaginal pessaries for the termination of pregnancy in the early second trimester. A comparison with extra-amniotic prostaglandin E2.
Cameron IT; Baird DT
Br J Obstet Gynaecol; 1984 Nov; 91(11):1136-40. PubMed ID: 6594157
[TBL] [Abstract][Full Text] [Related]
20. Efficacy of misoprostol in controlling indomethacin induced fecal blood loss in arthritic patients.
Jallad NS; Cattan A; Weidler DJ
Int J Clin Pharmacol Ther Toxicol; 1993 Aug; 31(8):376-81. PubMed ID: 8225682
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
